Join the Plaque Psoriasis group to help and get support from people like you.
Plaque Psoriasis News
Real-World Study Shows Effectiveness of Ixekizumab for Psoriasis
FRIDAY, Feb. 28, 2025 – For patients with moderate-to-severe plaque psoriasis, ixekizumab is effective and safe, with induction therapy enhancing initial response, according to a study published...
Childhood Maltreatment May Up Risk for Immune-Mediated Inflammatory Disorders
THURSDAY, Jan. 23, 2025 – On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders (IMIDs), according to a study...
FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara
JERSEY CITY, N.J., Dec. 17, 2024 – Celltrion announced today that the U.S. Food and Drug Administration (FDA) has approved Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), for...
High Ultraprocessed Food Intake Linked to Active Psoriasis
TUESDAY, Dec. 3, 2024 – High ultraprocessed food (UPF) intake is associated with active psoriasis, according to a research letter published online Nov. 27 in JAMA Dermatology. Laetitia Penso, Ph.D.,...
FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
Bengaluru, Karnataka, India, December 01, 2024 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced ...
Ultraprocessed Foods Might Help Trigger Psoriasis
WEDNESDAY, Nov. 27, 2024 – Ultraprocessed foods have been linked to a myriad of health issues, and a new study suggests that the autoimmune skin disease psoriasis might be added to that list....
FDA Approves Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara
RALEIGH, N.C., Oct. 14, 2024 /PRNewswire/ – Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care...
FDA Approves Otulfi (ustekinumab-aauz), a Biosimilar to Stelara
September 30, 2024 – Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic...
Home-Based Phototherapy as Effective as Office-Based for Psoriasis
MONDAY, Sept. 30, 2024 – For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept....
Obese Kids May Face Higher Odds for Eczema, Psoriasis
WEDNESDAY, Aug. 21, 2024 – Obese kids are more likely to develop immune-based skin problems like eczema or psoriasis, a new study says. Analysis of more than 2.1 million Korean children between 2009...
Racial Differences Identified in Frequency of Biopsy for Psoriasis
FRIDAY, Aug. 9, 2024 – There are racial differences in the frequency of skin biopsy for psoriasis, indicating diagnostic uncertainty, according to a research letter published online Aug. 7 in JAMA...
Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy
MONDAY, July 29, 2024 – Psoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve. Pietro E. ...
Air Pollution Exposure Tied to New Psoriasis
THURSDAY, July 18, 2024 – Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open. Junhui Wu, ...
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
MONDAY, July 1, 2024 – Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American...
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...
Further information
Related condition support groups
Related drug support groups
methylprednisolone, Humira, Enbrel, Stelara, Remicade, Otezla, Cosentyx, dexamethasone, Skyrizi, view more... adalimumab, etanercept, halobetasol, ustekinumab, Cimzia, Taltz